Skip to main content

Find out what is new at BMC Cancer

Goings on

On this page readers will find featured content, news updates and announcements from BMC Cancer. Come back often to find out what’s new at our journal.

Covid-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

New collection: Advances in CAR-T immunotherapy

New Content Item (1)

BMC Biotechnology and BMC Cancer together present the latest collection of articles on the advances in CAR-T immunotherapy covering the entire range of advances from lab to clinic. See the full collection of articles here.

Conference attendance

New Content Item © ©London Global Cancer Week

London Global Cancer Week 2019 - Cancer control in low and middle income countries - New Solutions to emerging challenges

BMC Cancer recently attended the 4th Meeting ‘Cancer control in low and middle income countries’ as part of the London Global Cancer Week at the Royal Society of Medicine on 25th Nov 2019. The meeting aimed to increase awareness of successful global cancer collaborations and provided an inspiring discuss forum. Here we touch upon the highlights of the meeting.

Editor's Pick

New Content Item

Are cancer patients better off if they participate in clinical trials? 

How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.

New Content Item © © Dr_Microbe/iStock

Early cancer detection - Machine learning enables detection of early-stage colorectal cancer  by whole-genome sequencing of cfDNA

Blood-based methods using cell-free DNA (cfDNA) are under development as an alternative to existing screening tests. However, detection of cancer using tumor-derived cfDNA has proven challenging. Dr. Putcha et al. show that a machine learning approach using cfDNA achieved high sensitivity and specificity in a large, early-stage, colorectal cancer cohort.

New Content Item © © haydenbird/iStock

SABR-COMET-10: Study protocol for a randomized Phase III Trial

Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment option for patients with oligometastatic disease. David Palma, Robert Olson and colleagues recently found that SABR was associated with benefits in progression-free survival and overall survival in the Phase II Trial. The goal of this international, Phase III Trial is to assess the impact of SABR in patients with 4–10 metastatic cancer lesions.

© ©iStock/unol

The design, analysis and application of mouse clinical trials in oncology drug development

Mouse clinical trials (MCTs) are becoming wildly used in pre-clinical oncology drug development but have lacked of the statistical framework. Sheng Guo and colleagues present general guidelines on the design, analysis and application to make MCTs a better tool in oncology research and drug development.

Editorial: Nobel Prize Cancer Immunotherapy!

New Content Item

Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery here.

Featured Blogs

World Cancer Day - Collection

New Content Item

We are committed to raising the quality of academic research in Oncology and Cancer Research. To mark World Cancer Day the Editors of Springer Nature have carefully selected the leading and most recent research published articles across portfolio and curated a blog addressing the impact of cancer beyond physical health. This year's theme is 'I Am and I Will', which is about your commitment to act.

The obesity-paradox: impact of body composition on cancer survival

© © Sherry Young / FotoliaDespite being a known risk factor for colon cancer, a new study has found obesity to be paradoxically associated with better survival in advanced stage colorectal cancer patients.

Divide and conquer: Tackling colorectal cancer

New Content ItemAwareness and treatment of colorectal cancer clearly needs to improve if we are going to increase patient survival rates and allow patients to live longer with a better quality of life. Associate Editor Professor Joanne Edwards and her team at Wolfson Wohl Cancer Research Centre develope biomarkers for personalised patient care and are establishing unique patient tissue cohorts with extensive linked clinical data across a breadth of solid tumours, including colorectal  cancer.

What is new at BMC Series?

Below you will find selected news from the BMC Series and Springer Nature.